Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

We Haven't Heard The End Of The Ketek Saga

Ketek (telithromycin) is an antibiotic first approved by the Food and Drug Administration in 2004. The Sanofi-Aventis product used to treat a form of pneumonia is the subject of ongoing controversy, with some fingers pointing at the company and some at the FDA.

But before February, when the FDA cut back the product's permitted uses, its indications also included "acute bacterial sinusitis and acute exacerbation of chronic bronchitis," says the FDA. The product is now labeled with a boxed warning (indicating seriousness) about use by patients with a particular health condition, and other strengthened warnings, along with a bolded warning about possible harm to the liver that was added in 2006.

But outside of the FDA's new stance toward the drug based on safety concerns, a separate drama is playing out. Congress has been asking questions about the FDA review of the product's safety before and after its approval, and some members have accused the FDA of stifling dissent from those who raised questions about the product's safety. The FDA's announcement of the labeling changes came just before a mid-February Congressional hearing into the agency's handling of the drug.

The controversies over Ketek, and other products such as Vioxx, which was withdrawn from the market altogether after safety issues arose, are helping fuel proposals to tighten FDA drug safety oversight. It remains to be seen what if any changes in the law Congress will make to address their concerns with the FDA's actions, but it's likely some changes will be made. They could include giving the FDA more powers over drug makers to monitor safety or an independent office to keep tabs on adverse drug effects.

By Eric Greenberg Attorney-at-Law www.ericfgreenbergpc.com
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?